Sling Therapeutics' $123M Raise Led Southeast Michigan VC in Q3
Sling Therapeutics' $123 million Q3 raise anchored a biotech-driven surge in Southeast Michigan VC, as investors concentrated capital in fewer, larger Ann Arbor deals.
Topic
Topic
Sling Therapeutics' $123 million Q3 raise anchored a biotech-driven surge in Southeast Michigan VC, as investors concentrated capital in fewer, larger Ann Arbor deals.